Alvotech (NASDAQ:ALVOW – Get Free Report) saw a large drop in short interest in the month of May. As of May 15th, there was short interest totaling 601 shares, a drop of 41.8% from the April 30th total of 1,032 shares. Based on an average daily volume of 4,491 shares, the short-interest ratio is presently 0.1 days.
Alvotech Price Performance
ALVOW traded up $0.03 during midday trading on Wednesday, hitting $0.20. 871 shares of the company were exchanged, compared to its average volume of 4,460. The company’s 50 day simple moving average is $0.25 and its 200 day simple moving average is $0.45. Alvotech has a 1-year low of $0.12 and a 1-year high of $3.00.
About Alvotech
Alvotech is a biopharmaceutical company specializing in the development and manufacturing of biosimilar medicines. Headquartered in Reykjavík, Iceland, the company focuses on creating high-quality, cost-effective alternatives to branded biologic therapies. Since its founding in 2013, Alvotech has built an integrated platform that spans research and development, clinical trials, regulatory submissions and commercial manufacturing.
Alvotech’s pipeline includes multiple biosimilar candidates addressing key therapeutic areas such as immunology, oncology and ophthalmology.
Read More
- Five stocks we like better than Alvotech
- Microsoft Build 2026 Is Really Just One Big AI Stress Test
- Slice of the Pie: Why Yum’s Deal Lifts QSR
- 3 Most Upgraded Stocks Last Month According to MarketBeat
- MongoDB Is the Latest SaaS Apocalypse Victim to Say “Not Today”
Receive News & Ratings for Alvotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alvotech and related companies with MarketBeat.com's FREE daily email newsletter.
